Last updated September 22, 2020
Medified Solutions processes your data with due care, in accordance with all applicable laws and regulations.
Medified Solution Oy ("Medified", "we", "us" or "our") has implemented this Privacy Policy to provide users of the Medified website (www.medified.fi) (Website) and the Mielipäiväkirja application (App) with information about how we collect, hold and use Information you provide to us through the Website or the App or if you email one of the contact emails listed on the Website or the App.
This Privacy Statement applies to all personal data that we processes during the execution of our services, including the personal data of visitors of the Medified Solutions websites. We may, from time to time, update this Privacy Statement, including to take into account new laws, regulations, practices and technology. All information collected by us through the Website or the App will be governed by our most recent Privacy Policy, posted on the Website and the App.
The following Privacy Statement explains what data we process, how we do that and how you may use your rights as a data subject and as an End-User (e.g. right to object and right of access). If you have any other questions or concerns about our policy, or our practices, feel free to contact us through this email. You can also download a pdf version from here.
The prevalence of Mental health disorders is constantly growing
883,7
Million
The total number of Healthcare visits
in the United States in 2018. (National Center of Health Statistic, 2018)
9,3 %
Percent of physician office visits with depression indicated on the medical record (NCHS, 2016)
82,2
Million
Estimation of Depression related healthcare visits in the United States in 2018.
Depression is on the rise in today’s high-tempo society. According to WHO 25% percent of the Europeans suffer from depression during their lifetime.
In Europe, the total cost of depression is estimated to be over 600 billion euros. In 2008, WHO ranked major depression as the third cause of burden of disease worldwide and projected that the disease will rank first by 2030. Antidepressants are one of the fastest-growing prescribed drugs in Western countries.
According to Lancet in practice, its detection, diagnosis, and management often pose challenges for clinicians because of its various presentations, unpredictable course and prognosis, and variable response to treatment.
+64 %
The increase in the percentage of people using antidepressants between 1999 and 2014. (APA, 2017)